AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8213020
Drug: Steroid/lidocaine injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid/lidocaine injections into the posterior neck muscles (group B)
Trial: 3924877
Drug: Mupirocin at
RxNorm normalized name: Mupirocin
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin at 2 mg/l
Trial: 3924877
Drug: Mupirocin at
RxNorm normalized name: Mupirocin
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin at various concentrations (0.015 to 0.06 mg/l)
Trial: 3924877
Drug: Mupirocin at
RxNorm normalized name: Mupirocin
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin at 2-4 mg/l
Trial: 3924877
Drug: Mupirocin at
RxNorm normalized name: Mupirocin
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin at 16 mg/l
Trial: 3924877
Drug: Mupirocin at
RxNorm normalized name: Mupirocin
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin at 32 mg/l
Trial: 3924877
Drug: Mupirocin at
RxNorm normalized name: Mupirocin
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin at 1.0 mg/l or more for 120 h
Trial: 3924877
Drug: Mupirocin at
RxNorm normalized name: Mupirocin
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin at 4 mg/l
Trial: 3924877
Drug: Mupirocin at
RxNorm normalized name: Mupirocin
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin at 40 mg/l
Trial: 3924877
Drug: 2% mupirocin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% mupirocin topical treatment
Trial: 23677131
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of simvastatin (n=40)
Trial: 21715526
Drug: Full-nut dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-nut dose (75 g/day mixed nuts)
Trial: 21715526
Drug: Half-nut dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-nut dose
Trial: 19302259
Drug: Adenosine infusion
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adenosine infusion (40 microg kg(‐1) min(‐1))
Trial: 378735
Drug: Amoxycillin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin (1 g 8-hourly orally for fourteen days)
Trial: 30390234
Drug: Dexlansoprazole 60
RxNorm normalized name: dexlansoprazole 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexlansoprazole 60 mg once daily (QD) during open-label healing phase
Trial: 30390234
Drug: Dexlansoprazole 30
RxNorm normalized name: dexlansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexlansoprazole 30 mg QD during double-blind maintenance phase
Trial: 30390234
Drug: Dexlansoprazole 60
RxNorm normalized name: dexlansoprazole 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexlansoprazole 60 mg QD
Trial: 25622239
Drug: Oral dydrogesterone
RxNorm normalized name: Dydrogesterone
DrugBank: Dydrogesterone (DB00378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral dydrogesterone Duphaston(®) (2× 10mg) administered two times daily
Trial: 25622239
Drug: Crinone 8%(®)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crinone 8%(®) vaginal progesterone gel (90mg) administered daily
Trial: 25622239
Drug: Oral dydrogesterone
RxNorm normalized name: Dydrogesterone
DrugBank: Dydrogesterone (DB00378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral dydrogesterone Duphaston(®)
Trial: 25622239
Drug: Crinone 8%(®)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crinone 8%(®) vaginal progesterone gel
Trial: 21337584
Drug: Preparation with
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation with fasting, water, laxatives, and antiflatulents (Group I)
Trial: 21337584
Drug: Preparation with
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation with fasting, water, and antiflatulents alone (Group II)
Trial: 21337584
Drug: Preparation with
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation with fasting and water alone (Group III)
Trial: 15048662
Drug: Psychological treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychological treatments for weight loss
Trial: 9566644
Drug: T4 or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T4 or T3 treatment for six months
Trial: 7827931
Drug: Suture-ligation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suture-ligation of the branches of the inferior thyroid arteries at the thyroid capsule
Trial: 2457767
Drug: alpha-human atrial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha-human atrial natriuretic peptide (alpha-hANP) infusion for 30 min
Trial: 10638893
Drug: Morphine (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (0.2 mg/kg)
Trial: 21475254
Drug: Education on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Education on smoking and oral health, vocational training on motivational interviewing, structured advice protocols
Trial: 18341680
Drug: Performance-enhancing dietary
RxNorm normalized name: Perform
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Performance-enhancing dietary supplement (DS) with 21 mg synephrine and 304 mg caffeine
Trial: 17947933
Drug: 250 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg/kg fructose-1,6-diphosphate (FDP)
Trial: 17947933
Drug: 2.5 mM
RxNorm normalized name: NeuroMatrix, 2.5 mm IDx2.5 cm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mM (1.4 g/L) fructose-1,6-diphosphate (FDP)
Trial: 11292009
Drug: Intravenous cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cocaine (30 mg/70 kg) at infusion rates of 2, 15, and 60 seconds
Trial: 11292009
Drug: Intravenous hydromorphone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydromorphone (3 mg/70 kg) at infusion rates of 2, 15, and 60 seconds
Trial: 11292009
Drug: Placebo at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo at infusion rates of 2, 15, and 60 seconds
Trial: 9596428
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg pseudoephedrine
Trial: 17138310
Drug: Moderate pressure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate pressure massage therapy
Trial: 17138310
Drug: Light pressure
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light pressure massage therapy
Trial: 21937367
Drug: Standard triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard triple treatment plus probiotic (lansoprazole, clarithromycin, amoxicillin, saccharomyces boulardii)
Trial: 21937367
Drug: Levofloxacin-based therapy
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin-based therapy (esomeprazole, levofloxacin, amoxicillin for 14 days)
Trial: 21937367
Drug: Levofloxacin-based triple
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin-based triple therapy (esomeprazole and amoxicillin for 5 days, followed by esomeprazole, levofloxacin, and metronidazole for 7 days)
Trial: 12701116
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) at a dose of 2,400 mg per day
Trial: 10939036
Drug: Theodrip (theophylline)
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Theodrip (theophylline) 4.8 mg/kg
Trial: 8627041
Drug: Combined live
RxNorm normalized name: fecal microbiota, live Enema [Rebyota]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V)
Trial: 8627041
Drug: Measles-mumps-rubella and
RxNorm normalized name: varicella-zoster virus vaccine live (Oka-Merck) strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Measles-mumps-rubella and varicella vaccines at separate injection sites
Trial: 2415097
Drug: Amino-oxyacetic acid
RxNorm normalized name: silk amino acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino-oxyacetic acid (50 or 75 mg, four times a day orally for one week)
Trial: 22606978
Drug: Lactulose (Gp‐L)
RxNorm normalized name: Lactulose
DrugBank: Lactulose (DB00581)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lactulose (Gp‐L)
Trial: 17980550
Drug: Amitriptyline (10mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (10mg/day to start, dose elevation of 10mg/week up to 50mg/day if tolerated for eight weeks)
Trial: 10523008
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg TU
Trial: 10523008
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg TU
Trial: 10523008
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg TU and 1000 mg TU
Trial: 7491882
Drug: 100 g
RxNorm normalized name: Berri-Freez 4.5 GM per 100 GM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g honey
Trial: 7491882
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g honey
Trial: 7491882
Drug: Glucose-fructose mixture
RxNorm normalized name: fructose / glucose / phosphoric acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-fructose mixture (35 g each)
Trial: 9505155
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g lactulose
Trial: 6176313
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (5‐FU and methyl‐CCNU)
Trial: 6176313
Drug: Combined modality
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined modality therapy (external radiotherapy of 5000 rad combined with chemotherapy)
Trial: 24565386
Drug: Ondansetrone 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetrone 4 mg
Trial: 24565386
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline 5 mL
Trial: 12148861
Drug: Interactive computer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interactive computer displays with scene magnification initially set 5% higher than VOR gain, 10 sessions of 30 minutes twice daily for 5 days
Trial: 10434216
Drug: Clonidine 0.2
RxNorm normalized name: CLONIDINE 0.2MG/24HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 0.2 mg (C2)
Trial: 10434216
Drug: Clonidine 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 0.4 mg (C4)
Trial: 10434216
Drug: Esmolol (E)
DrugBank: Esmolol (DB00187)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Esmolol (E) 300 micrograms.kg‐1 followed by a continuous infusion of 160 micrograms.kg‐1.min‐1
Trial: 597688
Drug: Modelling and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modelling and role‐rehearsal + daily social homework
Trial: 29231316
Drug: Pregabalin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (75 mg, twice a day)
Trial: 23460328
Drug: Whole-body vibration
RxNorm normalized name: Insects (whole body), mite dermatophagoides farinae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-body vibration therapy (WBVT) for 8 weeks starting from 1 month postoperatively
Trial: 21278620
Drug: 20-mg IS-5-MN
RxNorm normalized name: IS 5-MN
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 20-mg IS-5-MN tablet
Trial: 17026606
Drug: Proview Eye
RxNorm normalized name: Proview Eye Pressure Monitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proview Eye Pressure Monitor used three times daily for 30 days as an adjunct to the glaucoma regimen
Trial: 17026606
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with no change in treatment regimen during the study phase
Trial: 9727991
Drug: Antibiotics (any)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics (any)
Trial: 9727991
Drug: More expensive
RxNorm normalized name: polyurethane-35 (not more than MPA.S at 40 %)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: More expensive antibiotics
Trial: 9727991
Drug: Amoxycillin and
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin and folate inhibitors
Trial: 785177
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of sodium-aescinat administered intravenously for 3 days
Trial: 785177
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of aescinat administered for 6 days
Trial: 23520221
Drug: High-intensity light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-intensity light therapy
Trial: 23520221
Drug: Low-intensity light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-intensity light therapy
Trial: 21875638
Drug: Chinese live
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese live attenuated hepatitis A vaccine (H2 strain)
Trial: 21875638
Drug: Domestic inactivated
RxNorm normalized name: domestic cow dander extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domestic inactivated hepatitis A vaccine (Healive(®))
Trial: 21875638
Drug: Imported inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imported inactivated hepatitis A vaccine (Havrix(®))
Trial: 21875638
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine (Control group)
Trial: 20141097
Drug: Various treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various treatment options including pharmacotherapy, implantable cardioverter‐defibrillators, cardiac resynchronization therapy, and heart transplantation.
Trial: 9812646
Drug: Composite Danshen
RxNorm normalized name: DANSHEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Composite Danshen Droplet Pills (CDDP)
Trial: 31976576
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral immunotherapy (OIT) with gradual increase to 53 mg/day for 1 year.
Trial: 27480813
Drug: Cognitive-behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural therapy intervention (CBTi) delivered by health-care assistants (HCAs) plus usual care
Trial: 20003316
Drug: Oral cholecalciferol
RxNorm normalized name: cholecalciferol Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cholecalciferol 2000 IU/day for 6 months
Trial: 8066868
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml carbocaine 1%
Trial: 8066868
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml isotonic NaCl (control)
Trial: 3184334
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral clindamycin (150 mg/d)
Trial: 4552431
Drug: Adrenaline (1/1,000)
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adrenaline (1/1,000) 0.5 ml
Trial: 30770424
Drug: Genetically instrumented
RxNorm normalized name: Burosumab (genetical recombination)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genetically instrumented vitamin D levels (increase of 10 nmol/L)
Trial: 22041889
Drug: pantoprazole 20
RxNorm normalized name: pantoprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pantoprazole 20 mg once daily
Trial: 11161416
Drug: Gemination at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemination at the root's end (e.g., SMM)
Trial: 10423595
Drug: Dirithromycin (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dirithromycin (two 250 mg tablets)
Trial: 7957504
Drug: 75 g
RxNorm normalized name: Zosyn 3.375 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 g glucose load
Trial: 7957504
Drug: 100 g
RxNorm normalized name: Berri-Freez 4.5 GM per 100 GM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g fat load
Trial: 31264958
Drug: Topical IOP-lowering
RxNorm normalized name: Avena sativa flowering top
DrugBank: Avena sativa flowering top (DB14253)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical IOP-lowering eyedrops (Medicine-1st)
Trial: 11523315
Drug: Enalapril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (20 mg o.d.)
Trial: 11523315
Drug: Losartan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50 mg o.d.)
Trial: 9761083
Drug: Niaspan alone
RxNorm normalized name: Niaspan
DrugBank: Niacin (DB00627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niaspan alone (median dose 2,000 mg)
Trial: 26879374
Drug: Abiraterone acetate
RxNorm normalized name: ABIRATERONE ACETATE
DrugBank: Abiraterone (DB05812)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Abiraterone acetate 1000 mg once daily plus prednisone 5 mg twice daily
Trial: 24323035
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus prednisone 5 mg twice daily
Trial: 24461175
Drug: Multi-disciplinary treatment
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-disciplinary treatment group (n=63)
Trial: 19473192
Drug: gluten-free diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gluten-free diet plus 6 mg budesonide daily
Trial: 19473192
Drug: budesonide (10-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: budesonide (10-30 microg/mL) in vitro
Trial: 15692317
Drug: PLAC (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PLAC (0.3 g.kg(‐1) body mass CaCO3 + 1 g NaCl)
Trial: 15692317
Drug: 0.3CIT (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3CIT (0.3 g.kg(‐1) body mass tri-sodium citrate)
Trial: 15692317
Drug: 0.5CIT (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5CIT (0.5 g.kg(‐1) body mass tri-sodium citrate)
Trial: 9745228
Drug: Sulbactam/cefoperazone (SBT/CPZ)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulbactam/cefoperazone (SBT/CPZ) administered simultaneously with fosfomycin (FOM)
Trial: 2116206
Drug: Intramuscular gold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular gold thiomalate
Trial: 23395546
Drug: 840 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 840 mg/day DHA and 270 mg/day EPA from fish oil capsules
Trial: 24568073
Drug: Placebo (olive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (olive oil capsules)
Trial: 21086216
Drug: Process-experiential emotion-focused
RxNorm normalized name: Allogeneic processed thymus tissue
DrugBank: Allogeneic processed thymus tissue (DB16736)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Process-experiential emotion-focused therapy
Trial: 17094744
Drug: Forced IV
RxNorm normalized name: benzalkonium chloride Topical Solution [Clean Force]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Forced IV hydration with 2 L of normal saline over 2 hours
Trial: 17094744
Drug: Minimal IV
RxNorm normalized name: Centipeda minima whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimal IV hydration at 20 mL of normal saline per hour
Trial: 15636426
Drug: DHEA 50
RxNorm normalized name: Natrol Mood & Stress DHEA 50mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA 50 mg/day for 4 months
Trial: 11791121
Drug: Tamoxifen, administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen, administered for 5 years
Trial: 11791121
Drug: Multi-agent chemotherapy
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-agent chemotherapy of 4-6 months duration
Trial: 7953984
Drug: 100 IU
RxNorm normalized name: Vitamin E 100 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 IU of intranasal salmon calcitonin (sCT)
Trial: 7953984
Drug: 200 IU
RxNorm normalized name: Vitamin E 200 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 IU of intranasal salmon calcitonin (sCT)
Trial: 7953984
Drug: 400 IU
RxNorm normalized name: Vitamin D 400 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 IU of intranasal salmon calcitonin (sCT)
Trial: 7953984
Drug: 200 IU
RxNorm normalized name: Vitamin E 200 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 IU and 400 IU of intranasal salmon calcitonin (sCT) pooled
Trial: 3699218
Drug: Topical clobetasol
RxNorm normalized name: clobetasol Topical Foam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical clobetasol propionate combined with dithranol and UVB
Trial: 31863962
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of bisphosphonate pamidronate within the first ten days of burn injury
Trial: 31863962
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of bisphosphonate pamidronate
Trial: 31863962
Drug: Serum from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum from patients given single dose bisphosphonate
Trial: 31863962
Drug: Antibody to
RxNorm normalized name: Antibody to HPA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibody to transforming growth factor beta (TGFβ)